Financials data is unavailable for this security.
Inc stmt in EURIncome statement in EURView more
Year on year
Faron Pharmaceuticals Oy's net income fell 35.46% from a loss of 21.21m to a larger loss of 28.73m despite flat revenues.
|Net profit margin||--|
|Return on assets||-234.98%|
|Return on equity||--|
|Return on investment||-844.50%|
Cash flow in EURView more
Faron Pharmaceuticals Oy did not generate a significant amount of cash. Cash Flow from Financing totalled 23.48m or -- of revenues. In addition the company used 22.99m for operations while cash used for investing totalled 385.00k.
|Cash flow per share||-0.4472|
|Price/Cash flow per share||--|
|Book value per share||-0.1667|
|Tangible book value per share||-0.1835|
Balance sheet in EURView more
|Total debt/total equity||--|
|Total debt/total capital||7.40|